Granted Patent
B2
US 7,655,245 · App. 10/864,684 · Granted Feb 2, 2010
Neisserial antigens
Assignee:
Novartis AG
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention provides proteins from Neisseria meningitidis (strains A & B) and from Neisseria gonorrhoeae , including amino acid sequences, the corresponding nucleotide sequences, expression data, and serological data. The proteins are useful antigens for vaccines, immunogenic compositions, and/or diagnostics.
Claims (5)
1. An isolated or recombinant polypeptide comprising:
(a) the amino acid sequence of SEQ ID NO: 650; or
(b) an amino acid sequence having 90% or greater sequence identity to (a).
2. The polypeptide of claim 1 comprising the amino acid sequence of SEQ ID NO: 650.
3. A composition comprising the protein of claims 1 or 2 and an adjuvant.
Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 20, 2009
From: SCARLATO, VINCENZO; MASIGNANI, VEGA; RAPPUOLI, RINO; PIZZA, MARIAGRAZIA; GRANDI, GUIDO
To: CHIRON SPA
Reel/Frame 023549/0984 →
CHANGE OF NAME
Recorded Nov 20, 2009
From: CHIRON SRL
To: NOVARTIS VACCINES AND DIAGNOSTICS SRL
Reel/Frame 023550/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 20, 2009
From: NOVARTIS VACCINES AND DIAGNOSTICS SRL
To: NOVARTIS AG
Reel/Frame 023550/0334 →
Priority Claims (7)
GB 19970023516
· Nov 6, 1997
· national
GB 19970024190
· Nov 14, 1997
· national
GB 19970024386
· Nov 18, 1997
· national
GB 19970025158
· Nov 27, 1997
· national
GB 19970026147
· Dec 10, 1997
· national
GB 19980000759
· Jan 14, 1998
· national
GB 19980019016
· Sep 1, 1998
· national
Continuity (3)
Continuation In Part
PCTIB980166500
· Oct 9, 1998